Excellence in research and development

of non-coding RNA DIAGnostics in ONcology

  • is establishing a strong academic-industrial consortium focused on research and development in the field of non-coding RNA diagnostics in oncology

  • enables the development of personal skills and knowledge of early-stage and experienced researchers from Europe through their long-term stays at the US research center of excellence, and traineeships at the education center and manufacturing facilities of an industrial partner

  • is increasing the scientific excellence and quality of related research in the participating EU research institutions

  • enables the dissemination of new technologies and approaches related to this field among other EU research institutions and interested public

​This project has received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska-  Curie grant agreement no. 824036 – RNADIAGON.

This website reflects only the author's view and the Research Executive Agency (REA) is not responsible for any use that may be made of the information it contains.